Navigation Links
Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Life Sciences & Diagnostics Bus Trip
Date:3/1/2011

CARLSBAD, Calif., March 1, 2011 /PRNewswire/ -- Life Technologies Corporation (Nasdaq: LIFE) today announced it will be webcasting management presentations to investors as part of the UBS West Coast Life Sciences & Diagnostics Bus Trip which is being held at the company's headquarters in Carlsbad on Monday, March 21st at 8:30 AM PT.  Mark Stevenson, Life Technologies' President and Chief Operating Officer, will present on behalf of the company.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

The webcast may be accessed from the Life Technologies' investor relations website at ir.lifetechnologies.com/events.cfm. The webcast will be available for 3 weeks following the presentation.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.

Contact Information:

Eileen Pattinson

760-603-7208

ir@lifetech.com




'/>"/>
SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Epeius Biotechnologies REXIN-G, a Tumor-Targeted Genetic Medicine for Metastatic Cancer, Gains Phase 3 Product Designation From the U.S. FDA
2. Honeywells Envergent Technologies to Demonstrate Renewable Fuel for Heat & Power at Crane & Companys Massachusetts Headquarters
3. Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
4. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
5. Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011
6. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
7. Life Technologies to Present at the Cowen and Company 31st Annual Health Care Conference
8. $3.5 Million Life Technologies Grant Will Help Train, Certify Forensic Scientists at UNT Health Science Center
9. Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011
10. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results
11. ISTO Technologies, Inc. to Present at Canaccord Genuitys Musculoskeletal Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
Breaking Biology News(10 mins):